Minoryx Therapeutics
Minoryx, they are committed to finding innovative treatments for life threatening rare diseases. They focus on pediatric diseases and they are currently working on treatments for neurometabolic diseases of genetic origin.Minoryx develops a new generation of small molecule drugs known as pharmacological chaperones, which offer the most promising approach to the treatment of genetic diseases severely affecting the central nervous system. As a complementary approach, Minoryx is also involved in repositioning-based projects.
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Minoryx Therapeutics use?+
Minoryx Therapeutics uses 11 technologies including Google Analytics, Google Tag Manager, OneTrust.
What industry is Minoryx Therapeutics in?+
Minoryx Therapeutics operates in the Biotechnology industry.
Where is Minoryx Therapeutics based?+
Minoryx Therapeutics is headquartered in Spain.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026